top of page

HELIXBIND TECHNOLOGY
Providing SPECIES LEVEL I.D.

25SCI-SEPSIS-articleLarge.jpg
iStock_000010775418Small.jpg

HelixBind’s tests incorporate multiple proprietary technologies, all of which are embedded on an easy-to-use disposable cassette that delivers test results within a few hours.

Delivering Cutting Edge Technology to Accelerate Accurate diagnosis
HelisBind.png
HELIXBIND tests deliver species level identification, across a broad MENU OF 20+ pathogenS, with sensitivity down to a few cells per milliliter, from a small blood sample, within a few hours.
READ

results in about

4 hours

LOAD

cassette into RaPID instrument

INSERT

3mL blood in a disposable cassette

Step-two.png
Tube-Steo-One.png
Arrow.png
Step-Three-.png
Arrow.png
Final-Step.jpg
4-hour-results.png

How HelixBind is Changing Care

Blood is perhaps the most complicated clinical specimen due to the presence of compounds which inhibit other tests as well as an abundance of human cells that far outnumber microbial cells in a sample by roughly a million times; there may be only a few microbial cells in each milliliter of blood. 

25SCI-SEPSIS-articleLarge.jpg

Sample preparation is critical and off the shelf methods were not designed and are not appropriate to address the complexity of bloodstream infections. HelixBind's proprietary methods covered by multiple patents address the myriad of challenges presented by bloodstream infections. HelixBind tests:

  • Can assay multiple milliliters of blood in a single test, maximizing sensitivity; 

  • Remove cell free microbial DNA that are not associated with an active infection;

  • Yield pure high molecular weight microbial genomic material, free of any downstream inhibitors.

Bloodstream infections are hard to identify and treat because there are many different microorganisms, some of which are challenging to differentiate, and many of which should be treated differently. The ability to detect and identify microorganisms is important. HelixBind has developed a patented method that utilizes artificial nucleic acids rather than DNA, which enables all HelixBind tests to:

  • Incorporate a comprehensive test menu of 20 of the most common and deadly bacteria and fungi in a single test;

  • Provide sufficient species level detail to guide treatment via targeted antimicrobials.

HelixBind tests are easy to operate and provide accurate results.

HelixBind has embedded the entire process onto a disposable plastic cassette. Everything has been automated, all the user has to do is snap the specimen tube into the cassette and load the cassette onto a small benchtop instrument. The tests have eliminated the need to open the specimen tube, making the test easier, safer, and less prone to contamination.

 

After the test is completed, the user is given a report with the findings:

  • Was a bloodstream infection found?

  • If so, what was the pathogen detected?

  • Were there any identified markers of antimicrobial resistance?

 

All of this information is both at the user’s fingertips as well as seamlessly interfaced with the hospital’s LIS for easy access.   

bottom of page